Company Filing History:
Years Active: 2015
Title: Shigetoshi Horiguchi: Innovator in Cancer Treatment
Introduction
Shigetoshi Horiguchi is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of cancer treatment, particularly in developing innovative methods for treating head and neck cancer. His work focuses on utilizing anti-cancer cell compositions to enhance the effectiveness of cellular immunotherapy.
Latest Patents
Horiguchi holds a patent for the "Use of anti-cancer cell composition for treatment of head and neck cancer." This patent outlines a method for efficiently delivering cells with anti-tumor activity directly to tumor tissues. The goal is to evoke a stronger anti-tumor reaction and achieve a more effective tumor regression effect. The method involves administering an anti-cancer cell composition containing NKT cells activated in vitro through the tumor-feeding artery, along with an NKT cell-stimulating agent via the upper respiratory tract mucous membrane.
Career Highlights
Horiguchi is affiliated with Chiba University, where he conducts research and develops innovative cancer treatment methodologies. His work has garnered attention for its potential to improve outcomes for patients suffering from head and neck cancer.
Collaborations
Horiguchi has collaborated with notable colleagues, including Masaru Taniguchi and Yoshitaka Okamoto. Their combined expertise contributes to advancing research in cancer immunotherapy.
Conclusion
Shigetoshi Horiguchi's innovative approaches to cancer treatment highlight the importance of research in developing effective therapies. His contributions are paving the way for improved patient care in oncology.